SCHEMBL6990912

SCHEMBL6990912

COc1ccc(/C=C2\Cc3cc(OC)ccc3C2=O)cc1

nearest known ligand 0.84

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
MAOB P27338 7/20 0.84
MAOA P21397 2/20 0.80
CYP19A1 P11511 2/20 0.80
CES2 O00748 2/20 0.73
ACHE P22303 5/20 0.71
BCHE P06276 1/20 0.70
BACE1 P56817 1/20 0.66
MIF P14174 5/20 0.65
CYP26A1 O43174 1/20 0.65
HRH3 Q9Y5N1 1/20 0.64

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30413650 1.00 MAOB (0.84) MAOBMAOACYP19A1CES2ACHE
SCHEMBL28927416 1.00 MAOB (0.84) MAOBMAOACYP19A1CES2ACHE
SCHEMBL30412163 0.93 MAOB (0.78) MAOBMAOACYP19A1CES2ACHE
SCHEMBL28927347 0.93 MAOB (0.78) MAOBMAOACYP19A1CES2ACHE
SCHEMBL29038294 0.93 CES2 (0.80) MAOBMAOACYP19A1CES2ACHE
SCHEMBL29038289 0.93 CES2 (0.80) MAOBMAOACYP19A1CES2ACHE
SCHEMBL6984448 0.92 MAOB (0.71) MAOBMAOACYP19A1CES2ACHE
SCHEMBL5581835 0.92 MAOB (0.76) MAOBMAOACYP19A1CES2ACHE
SCHEMBL28927366 0.92 MAOB (0.76) MAOBMAOACYP19A1CES2ACHE
SCHEMBL5581839 0.92 MAOB (0.76) MAOBMAOACYP19A1CES2ACHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116283657-B Indenone derivative and synthetic method and application thereof 贵州大学 2024-08-20 CN disclosed
CN-116283657-A Indenone derivative and synthetic method and application thereof 贵州大学 2023-06-23 CN disclosed
US-9682919-B2 Small molecule inhibitors of Dusp6 and uses therefor University of Pittsburgh—of the Commonwealth System of Higher Education (US) 2017-06-20 US disclosed
US-20160355459-A1 Small Molecule Inhibitors of Dusp6 and Uses Therefor UNIVERSITY OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION 2016-12-08 US disclosed
US-9439877-B2 Small molecule inhibitors of Dusp6 and uses therefor University of Pittsburgh—of the Commonwealth System of Higher Education (US) 2016-09-13 US disclosed
US-20160113889-A1 Small Molecule Inhibitors of Dusp6 and Uses Therefor UNIVERSITY OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION 2016-04-28 US disclosed
US-9127016-B2 Small molecule inhibitors of Dusp6 and uses therefor University of Pittsburgh—of the Commonwealth System of Higher Education (US) 2015-09-08 US disclosed
US-20120122992-A1 SMALL MOLECULE INHIBITORS OF Dusp6 AND USES THEREFOR University of Pittsburgh-Of the Commonwealth Syste (US) 2012-05-17 US disclosed
WO-2010108058-A2 SMALL MOLECULE INHIBITORS OF DUSP6 AND USES THEREFOR UNIVERSITY OF PITTSBURGH-OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) 2010-09-23 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160113889-A1 Small Molecule Inhibitors of Dusp6 and Uses Therefor DUSP26, DUSP6, DUSP2 MAOB 4129/4885MAOA 4194/4885CYP19A1 4462/4885
US-20160355459-A1 Small Molecule Inhibitors of Dusp6 and Uses Therefor DUSP26, DUSP6, DUSP2 MAOB 4129/4885MAOA 4194/4885CYP19A1 4462/4885
US-20120122992-A1 SMALL MOLECULE INHIBITORS OF Dusp6 AND USES THEREFOR DUSP26, DUSP6, DUSP2 MAOB 4129/4885MAOA 4194/4885CYP19A1 4462/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.